Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Radiofrequency Ablation in Treating Patients With Bone Metastases

ClinicalTrials.gov ID: NCT00026247

Public ClinicalTrials.gov record NCT00026247. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 11:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study of Percutaneous Radiofrequency Ablation of Bone Metastases Using CT Guidance

Study identification

NCT ID
NCT00026247
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
American College of Radiology Imaging Network
Network
Enrollment
66 participants

Conditions and interventions

Interventions

  • pain therapy Procedure
  • radiofrequency ablation Procedure

Procedure

Eligibility (public fields only)

Age range
21 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2001
Primary completion
Feb 14, 2010
Completion
Feb 14, 2010
Last update posted
Jul 4, 2019

2001 – 2010

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham Alabama 35294
UMASS Memorial Cancer Center - University Campus Worcester Massachusetts 01655
Mallinckrodt Institute of Radiology at Washington University Medical Center St Louis Missouri 63110
Radiology Consultants, Incorporated Youngstown Ohio 44512
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104-4283
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107-5541
Comprehensive Cancer Center at Rhode Island Hospital Providence Rhode Island 02903
M.D. Anderson Cancer Center at University of Texas Houston Texas 77030-4009

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00026247, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 4, 2019 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00026247 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →